IFIH1 and retinitis pigmentosa 1: In addition, patients with anti-MDA5 antibodies usually show relatively mild dysfunction in daily life after RP-ILD improves, although some patients may succumb to respiratory failure caused by RP-ILD despite immunosuppressive therapies.